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Abstract 
A total of 360 weanling barrows (PIC 1050, 21 d of age and 13.0 lb) were used in a 35-d study to evaluate 
the effects of porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) vaccines on 
nursery pig growth performance. Two commercial PCV2 vaccines were evaluated in this study: (1) a 
2-dose product, Circumvent PCV (Circumvent; Intervet/Schering-Plough Animal Health, Millsboro, DE) and 
(2) a 1-dose product, Ingelvac CircoFLEX (CircoFLEX; Boehringer Ingelheim Vetmedica, Inc, St. Joseph, 
MO). For the M. hyo vaccine, RespiSure (Pfizer Animal Health, New York, NY), a single 2-dose product, was 
used. At weaning (d 0), pens of pigs were blocked by average pig weight and randomly allotted to 1 of 6 
treatments in a 3 Ã— 2 factorial arrangement composed of a combination of PCV2 vaccine (Circumvent, 
CircoFLEX, or non-PCV2-vaccinated control) and M. hyo vaccine (RespiSure or non-M. hyo-vaccinated 
control). There were 5 pigs per pen and 12 pens per PCV2 Ã— M. hyo vaccine treatment. All vaccines 
were administered according to label directionsâ€” CircoFLEX at weaning and Circumvent and RespiSure 
at weaning and 21 d later. Common diets were fed by phase to all pigs. There were no PCV2 Ã— M. hyo 
vaccine interactions for any response criteria. Overall, pigs vaccinated with Circumvent had decreased 
ADG (P < 0.02) and ADFI (P â‰¤ 0.01) compared with CircoFLEX-vaccinated and control pigs, 
respectively. On d 35, Circumvent- vaccinated pigs weighed less (42.9 lb, P < 0.01) than pigs vaccinated 
with CircoFLEX (44.4 lb) or control pigs (44.4 lb). Pigs vaccinated with RespiSure had decreased ADG 
compared with control pigs (P â‰¤ 0.05) from d 14 to 21 and d 21 to 25. On d 35, RespiSure-vaccinated 
pigs tended to weigh less (43.5 lb, P = 0.06) and have lower ADFI (P = 0.06) than controls (wt = 44.3 lb). 
These data indicate that PCV2 and M. hyo vaccination can independently reduce feed intake and 
performance of nursery pigs and that the PCV2 vaccine effect is product dependent. Although PCV2 and 
M. hyo vaccines are known to improve finishing performance, their negative impact on nursery 
performance must be considered when implementing vaccine strategies.; Swine Day, Manhattan, KS, 
November 19, 2009 
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Table 1. Effect of PCV2 vaccines on nursery pig growth performance, feed intake, and 
feed efficiency1
PCV2	treatment2
Item	 Control Circumvent CircoFLEX SEM
d	0	to	8
					ADG,	lb 0.28 0.26 0.29 0.02
					ADFI,	lb 0.28ab 0.26a 0.29b 0.01
					F/G 1.02 1.03 1.04 0.03
d	8	to	14
					ADG,	lb 0.73 0.68 0.70 0.03
					ADFI,	lb 0.96a 0.87b 0.95a 0.04
					F/G 1.31 1.29 1.37 0.03
d	14	to	21
					ADG,	lb 1.04 1.03 1.02 0.03
					ADFI,	lb 1.55 1.48 1.54 0.04
					F/G 1.50ab 1.45a 1.52b 0.03
d	21	to	29
					ADG,	lb 1.07a 0.96b 1.10a 0.03
					ADFI,	lb 1.70a 1.57b 1.72a 0.04
					F/G 1.60 1.65 1.58 0.03
d	29	to	35
					ADG,	lb 1.50 1.48 1.50 0.04
					ADFI,	lb 2.20 2.16 2.25 0.06
					F/G 1.47 1.46 1.51 0.02
d	0	to	35
					ADG,	lb 0.89a 0.85b 0.90a 0.02
					ADFI,	lb 1.29a 1.23b 1.32a 0.03
					F/G 1.45 1.45 1.47 0.01
Weight,	lb
					d	0 12.9 13.0 13.0 0.6
					d	21 26.9 26.3 26.6 0.9









Table 2. Effect of M.	hyo vaccines on nursery pig growth performance, feed intake, and 
feed efficiency1
M. hyo	treatment2
Item	 Control RespiSure SEM Probability,	P <
d	0	to	8
					ADG,	lb 0.28 0.27 0.01 0.44
					ADFI,	lb 0.28 0.27 0.01 0.40
					F/G 1.03 1.03 0.03 0.88
d	8	to	14
					ADG,	lb 0.69 0.72 0.03 0.10
					ADFI,	lb 0.93 0.93 0.04 0.82
					F/G 1.35 1.29 0.02 0.06
d	14	to	21
					ADG,	lb 1.05 1.01 0.03 0.05
					ADFI,	lb 1.54 1.51 0.04 0.25
					F/G 1.47 1.50 0.02 0.23
d	21	to	29
					ADG,	lb 1.07 1.01 0.03 0.02
					ADFI,	lb 1.71 1.62 0.04 <0.01
					F/G 1.61 1.60 0.02 0.80
d	29	to	35
					ADG,	lb 1.51 1.48 0.04 0.31
					ADFI,	lb 2.24 2.16 0.06 0.03
					F/G 1.49 1.47 0.02 0.26
d	0	to	35
					ADG,	lb 0.89 0.87 0.02 0.10
					ADFI,	lb 1.30 1.26 0.03 0.06
					F/G 1.46 1.45 0.01 0.57
Weight,	lb
					d	0 12.9 13.0 0.6 0.22
					d	21 26.7 26.5 0.9 0.50


























PCV2 × M. hyo: P = 0.68
SEM = 1.3




0).	M. hyo	vaccine	treatments	were:	M. hyo	controls	(No	M. hyo	vaccine)	and	RespiSure	(pigs	
vaccinated	with	2	mL	RespiSure	administered	intramuscularly	on	d	0	and	21.)
